nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—Conjunctivitis—Auranofin—psoriatic arthritis	0.0305	0.0305	CcSEcCtD
Bretylium—Hiccups—Prednisolone—psoriatic arthritis	0.0179	0.0179	CcSEcCtD
Bretylium—Hiccups—Triamcinolone—psoriatic arthritis	0.0165	0.0165	CcSEcCtD
Bretylium—Hiccups—Methylprednisolone—psoriatic arthritis	0.0164	0.0164	CcSEcCtD
Bretylium—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.0164	0.0164	CcSEcCtD
Bretylium—Abdominal pain—Auranofin—psoriatic arthritis	0.0158	0.0158	CcSEcCtD
Bretylium—Hiccups—Dexamethasone—psoriatic arthritis	0.0149	0.0149	CcSEcCtD
Bretylium—Hiccups—Betamethasone—psoriatic arthritis	0.0149	0.0149	CcSEcCtD
Bretylium—Diarrhoea—Auranofin—psoriatic arthritis	0.0137	0.0137	CcSEcCtD
Bretylium—Hiccups—Prednisone—psoriatic arthritis	0.013	0.013	CcSEcCtD
Bretylium—Affect lability—Prednisolone—psoriatic arthritis	0.0128	0.0128	CcSEcCtD
Bretylium—Vomiting—Auranofin—psoriatic arthritis	0.0127	0.0127	CcSEcCtD
Bretylium—Mood swings—Prednisolone—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Bretylium—Nausea—Auranofin—psoriatic arthritis	0.0119	0.0119	CcSEcCtD
Bretylium—Affect lability—Triamcinolone—psoriatic arthritis	0.0118	0.0118	CcSEcCtD
Bretylium—Affect lability—Methylprednisolone—psoriatic arthritis	0.0117	0.0117	CcSEcCtD
Bretylium—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.0116	0.0116	CcSEcCtD
Bretylium—Mood swings—Triamcinolone—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Bretylium—Mood swings—Methylprednisolone—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Bretylium—Lethargy—Dexamethasone—psoriatic arthritis	0.0111	0.0111	CcSEcCtD
Bretylium—Lethargy—Betamethasone—psoriatic arthritis	0.0111	0.0111	CcSEcCtD
Bretylium—Sweating increased—Prednisolone—psoriatic arthritis	0.0109	0.0109	CcSEcCtD
Bretylium—Affect lability—Betamethasone—psoriatic arthritis	0.0107	0.0107	CcSEcCtD
Bretylium—Affect lability—Dexamethasone—psoriatic arthritis	0.0107	0.0107	CcSEcCtD
Bretylium—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Bretylium—Psychotic disorder—Betamethasone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Bretylium—Mood swings—Dexamethasone—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Bretylium—Mood swings—Betamethasone—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Bretylium—Sweating increased—Triamcinolone—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Bretylium—Sweating increased—Methylprednisolone—psoriatic arthritis	0.01	0.01	CcSEcCtD
Bretylium—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00973	0.00973	CcSEcCtD
Bretylium—Lethargy—Prednisone—psoriatic arthritis	0.00963	0.00963	CcSEcCtD
Bretylium—Affect lability—Prednisone—psoriatic arthritis	0.00929	0.00929	CcSEcCtD
Bretylium—Psychotic disorder—Prednisone—psoriatic arthritis	0.00922	0.00922	CcSEcCtD
Bretylium—Bradycardia—Prednisolone—psoriatic arthritis	0.00915	0.00915	CcSEcCtD
Bretylium—Sweating increased—Betamethasone—psoriatic arthritis	0.00913	0.00913	CcSEcCtD
Bretylium—Sweating increased—Dexamethasone—psoriatic arthritis	0.00913	0.00913	CcSEcCtD
Bretylium—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00895	0.00895	CcSEcCtD
Bretylium—Mood swings—Prednisone—psoriatic arthritis	0.00894	0.00894	CcSEcCtD
Bretylium—Bradycardia—Triamcinolone—psoriatic arthritis	0.00841	0.00841	CcSEcCtD
Bretylium—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00839	0.00839	CcSEcCtD
Bretylium—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00812	0.00812	CcSEcCtD
Bretylium—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00812	0.00812	CcSEcCtD
Bretylium—Lethargy—Methotrexate—psoriatic arthritis	0.00805	0.00805	CcSEcCtD
Bretylium—Sweating increased—Prednisone—psoriatic arthritis	0.00795	0.00795	CcSEcCtD
Bretylium—Bradycardia—Betamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Bretylium—Bradycardia—Dexamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Bretylium—Mood swings—Methotrexate—psoriatic arthritis	0.00747	0.00747	CcSEcCtD
Bretylium—Vertigo—Prednisolone—psoriatic arthritis	0.00703	0.00703	CcSEcCtD
Bretylium—Syncope—Prednisolone—psoriatic arthritis	0.00702	0.00702	CcSEcCtD
Bretylium—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00688	0.00688	CcSEcCtD
Bretylium—Hypertension—Prednisolone—psoriatic arthritis	0.00675	0.00675	CcSEcCtD
Bretylium—Bradycardia—Prednisone—psoriatic arthritis	0.00665	0.00665	CcSEcCtD
Bretylium—Vertigo—Triamcinolone—psoriatic arthritis	0.00646	0.00646	CcSEcCtD
Bretylium—Syncope—Triamcinolone—psoriatic arthritis	0.00645	0.00645	CcSEcCtD
Bretylium—Vertigo—Methylprednisolone—psoriatic arthritis	0.00645	0.00645	CcSEcCtD
Bretylium—Syncope—Methylprednisolone—psoriatic arthritis	0.00644	0.00644	CcSEcCtD
Bretylium—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00632	0.00632	CcSEcCtD
Bretylium—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00631	0.00631	CcSEcCtD
Bretylium—Shock—Prednisolone—psoriatic arthritis	0.00628	0.00628	CcSEcCtD
Bretylium—Hypertension—Triamcinolone—psoriatic arthritis	0.00621	0.00621	CcSEcCtD
Bretylium—Hypertension—Methylprednisolone—psoriatic arthritis	0.0062	0.0062	CcSEcCtD
Bretylium—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00617	0.00617	CcSEcCtD
Bretylium—Anxiety—Methylprednisolone—psoriatic arthritis	0.00609	0.00609	CcSEcCtD
Bretylium—Flushing—Prednisone—psoriatic arthritis	0.00606	0.00606	CcSEcCtD
Bretylium—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00591	0.00591	CcSEcCtD
Bretylium—Confusional state—Methylprednisolone—psoriatic arthritis	0.00591	0.00591	CcSEcCtD
Bretylium—Vertigo—Betamethasone—psoriatic arthritis	0.00586	0.00586	CcSEcCtD
Bretylium—Vertigo—Dexamethasone—psoriatic arthritis	0.00586	0.00586	CcSEcCtD
Bretylium—Syncope—Betamethasone—psoriatic arthritis	0.00585	0.00585	CcSEcCtD
Bretylium—Syncope—Dexamethasone—psoriatic arthritis	0.00585	0.00585	CcSEcCtD
Bretylium—Shock—Triamcinolone—psoriatic arthritis	0.00578	0.00578	CcSEcCtD
Bretylium—Shock—Methylprednisolone—psoriatic arthritis	0.00576	0.00576	CcSEcCtD
Bretylium—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00574	0.00574	CcSEcCtD
Bretylium—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00574	0.00574	CcSEcCtD
Bretylium—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00568	0.00568	CcSEcCtD
Bretylium—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00566	0.00566	CcSEcCtD
Bretylium—Hypertension—Dexamethasone—psoriatic arthritis	0.00564	0.00564	CcSEcCtD
Bretylium—Hypertension—Betamethasone—psoriatic arthritis	0.00564	0.00564	CcSEcCtD
Bretylium—Anxiety—Betamethasone—psoriatic arthritis	0.00554	0.00554	CcSEcCtD
Bretylium—Anxiety—Dexamethasone—psoriatic arthritis	0.00554	0.00554	CcSEcCtD
Bretylium—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00526	0.00526	CcSEcCtD
Bretylium—Shock—Betamethasone—psoriatic arthritis	0.00524	0.00524	CcSEcCtD
Bretylium—Shock—Dexamethasone—psoriatic arthritis	0.00524	0.00524	CcSEcCtD
Bretylium—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00523	0.00523	CcSEcCtD
Bretylium—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00515	0.00515	CcSEcCtD
Bretylium—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00515	0.00515	CcSEcCtD
Bretylium—Vertigo—Prednisone—psoriatic arthritis	0.00511	0.00511	CcSEcCtD
Bretylium—Syncope—Prednisone—psoriatic arthritis	0.0051	0.0051	CcSEcCtD
Bretylium—Loss of consciousness—Prednisone—psoriatic arthritis	0.005	0.005	CcSEcCtD
Bretylium—Hypertension—Prednisone—psoriatic arthritis	0.00491	0.00491	CcSEcCtD
Bretylium—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00484	0.00484	CcSEcCtD
Bretylium—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Bretylium—Anxiety—Prednisone—psoriatic arthritis	0.00482	0.00482	CcSEcCtD
Bretylium—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00479	0.00479	CcSEcCtD
Bretylium—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00464	0.00464	CcSEcCtD
Bretylium—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00463	0.00463	CcSEcCtD
Bretylium—Shock—Prednisone—psoriatic arthritis	0.00456	0.00456	CcSEcCtD
Bretylium—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00448	0.00448	CcSEcCtD
Bretylium—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Bretylium—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Bretylium—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Bretylium—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Bretylium—Vertigo—Methotrexate—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Bretylium—Dizziness—Prednisolone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Bretylium—Abdominal pain—Betamethasone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Bretylium—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Bretylium—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Bretylium—Body temperature increased—Betamethasone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Bretylium—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Bretylium—Confusional state—Methotrexate—psoriatic arthritis	0.00391	0.00391	CcSEcCtD
Bretylium—Dizziness—Triamcinolone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Bretylium—Dizziness—Methylprednisolone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Bretylium—Feeling abnormal—Prednisone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Bretylium—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Bretylium—Nausea—Prednisolone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Bretylium—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Bretylium—Vomiting—Triamcinolone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Bretylium—Vomiting—Methylprednisolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Bretylium—Abdominal pain—Prednisone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Bretylium—Body temperature increased—Prednisone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Bretylium—Diarrhoea—Betamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Bretylium—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Bretylium—Dizziness—Betamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Bretylium—Dizziness—Dexamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Bretylium—Nausea—Triamcinolone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Bretylium—Nausea—Methylprednisolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Bretylium—Dyspnoea—Methotrexate—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Bretylium—Vomiting—Betamethasone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Bretylium—Vomiting—Dexamethasone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Bretylium—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Bretylium—Diarrhoea—Prednisone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Bretylium—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Bretylium—Nausea—Betamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Bretylium—Nausea—Dexamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Bretylium—Dizziness—Prednisone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Bretylium—Abdominal pain—Methotrexate—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Bretylium—Body temperature increased—Methotrexate—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Bretylium—Vomiting—Prednisone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Bretylium—Nausea—Prednisone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Bretylium—Diarrhoea—Methotrexate—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Bretylium—Dizziness—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Bretylium—Vomiting—Methotrexate—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Bretylium—Nausea—Methotrexate—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
